Treatment of non-small cell lung cancer based on the theory of “lungs as the blood organ”

Yuxiao Gou; Zihan Wang; Yuhan Wei; Shengjun Sun; Meng Dong; Yongqi Kang; Jiansen Chang; Wenjie Chen

doi:10.54254/3049-5458/1/2024003

Article Information

Received: 30 May 2024

Published: 29 April 2024

DOI: https://doi.org/10.54254/3049-5458/1/2024003

Article Type: Research Article

Cite this article

Gou,Y.;Wang,Z.;Wei,Y.;Sun,S.;Dong,M.;Kang,Y.;Chang,J.;Chen,W. (2024). Treatment of non-small cell lung cancer based on the theory of “lungs as the blood organ”. Journal of Clinical Technology and Theory,1,13-18.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About this Volume

Volume Title: JCTT Vol.1

Part of Series: Journal of Clinical Technology and Theory

ISSN: 3049-5458 (Print) / 3049-5466 (Online)

Copyright & License

[1]Wang, J., Xiao, M., Ma, G., et al. (2023). Research progress of traditional Chinese medicine treatment in non-small cell lung cancer. Shaanxi Traditional Chinese Medicine, 44(11), 1663-1665.

[2]Zhao, L. (2024). Efficacy observation of gefitinib in the treatment of advanced non-small cell lung cancer with targeted therapy. Chinese Journal of Modern Drug Application, 18(04), 82-84. DOI:10.14164/j.cnki.cn11-5581/r.2024.04.022.

[3]Zhang, W., & Guo, M. (2012). On the theory of “lungs as the source of blood” and promoting blood circulation to remove blood stasis. Jilin Journal of Traditional Chinese Medicine, 32(07), 649-651. DOI:10.13463/j.cnki.jlzyy.2012.07.010.

[4]Gu, Y., Wang, Y., Qi, A., et al. (2023). Stage-wise rehabilitation treatment strategy of traditional Chinese medicine after surgery for non-small cell lung cancer. Shanghai Journal of Traditional Chinese Medicine, 57(06), 16-19. DOI:10.16305/j.1007-1334.2023.2211037.

[5]Chen, J., Qiu, L., Wang, L., et al. (2024). Research progress on the potential role of Chinese medicine in the treatment of non-small cell lung cancer. Chinese Traditional Patent Medicine, 46(01), 204-210.

[6]Zhang, Q., Li, J., & Yao, J. (2023). Research progress of tonifying qi and nourishing yin method in the clinical treatment of advanced non-small cell lung cancer. Journal of Traditional Chinese Medicine and Clinical Research, 35(04), 818-823. DOI:10.16448/j.cjtcm.2023.0439.

[7]Zhang, B., & Wu, M. (2012). Application of tonifying qi and nourishing yin method in comprehensive treatment of patients with advanced non-small cell lung cancer. Journal of Traditional Chinese Medicine Herald, 18(11), 110-111. DOI:10.13862/j.cnki.cn43-1446/r.2012.11.031.

[8]Su, S., Lu, X., Huang, Y., et al. (2023). Introduction of Zhou Jihong’s experience in using tonifying the body and fighting cancer method to treat lung cancer. New Chinese Medicine, 55(10), 100-105. DOI:10.13457/j.cnki.jncm.2023.10.021.

[9]Yu, H. (2023). Research on the system of syndrome differentiation and treatment of hand Taiyin lung meridian diseases in “Lingshu Jingmai” [Master’s thesis, Liaoning University of Traditional Chinese Medicine]. DOI:10.27213/d.cnki.glnzc.2023.000426.

[10]Chen, X., Ning, Y., Wang, Y., et al. (2024). Experience of famous Chinese medicine practitioner Wang Ruiping in using “nurturing soil to generate gold method” to treat lung cancer. Shaanxi Traditional Chinese Medicine, 45(04), 536-540.

[11]Jiang, W., Li, Z., Jiang, C., et al. (2021). Molecular mechanism and prognosis analysis of tonifying qi and nourishing yin drugs in the treatment of advanced lung cancer. Chinese Medicine Modern Distance Education, 19(07), 205-208.

[12]Chen, W., Zhang, N., & Hu, M. (2023). Effects of tonifying qi, nourishing yin, and promoting blood circulation method on vascular neogenesis in rats with idiopathic pulmonary fibrosis. Western Chinese Medicine, 36(09), 14-18.

[13]Liu, X., & Wu, M. (2023). Experience of Wu Mianhua in the treatment of lung cancer. Chinese Journal of Traditional Chinese Medicine Information on Books and Literature, 47(02), 87-89.

[14]Jiao, J., Li, Y., Shang, Y., et al. (2021). Efficacy of Qishe Yifei Decoction in assisting the treatment of elderly patients with advanced non-small cell lung cancer and its effects on immune function, serum P53, and Survivin. Sichuan Traditional Chinese Medicine, 39(06), 123-126.

[15]Wang, X., & Sun, J. (2021). Effect of Ginseng and Astragalus Lung-Enriching Decoction combined with Nivolumab on immune function and quality of life in patients with advanced NSCLC. Journal of Integrated Traditional Chinese and Western Medicine Research, 13(04), 221-225.

[16]Qiao, X. (2022). Analysis of the efficacy of Spleen-tonifying and Kidney-nourishing Decoction in the adjuvant treatment of advanced non-small cell lung cancer with negative driving gene. Journal of Practical Traditional Chinese Medicine, 38(03), 409-411.

[17]Wang, J., Lin, Y., Li, H., et al. (2020). Effects of Tonifying Kidney and Lung, Detoxifying Formula combined with chemotherapy on serum Foxp3 and B7-H3 expression in patients with lung and kidney deficiency type advanced non-small cell lung cancer. Journal of Modern Integrated Chinese and Western Medicine, 29(15), 1608-1611.

[18]Yang, F., Song, L., Fan, R., et al. (2020). Discussion on latent cytomegalovirus pneumonia from the perspective of “lungs as the source of blood”. Chinese Journal of Traditional Chinese Medicine, 35(11), 5446-5448.

[19]Tian, M., & Zhang, W. (2014). On the theory of “lungs as the source of blood”. Chinese Journal of Traditional Chinese Medicine, 29(03), 680-682.

[20]Huang, L., & Zhang, W. (2020). Significance of discussing the role of stasis in bronchial asthma from the perspective of “lungs as the source of blood”. Liaoning Journal of Traditional Chinese Medicine, 47(02), 74-75. DOI:10.13192/j.issn.1000-1719.2020.02.022.

[21]Wang, J., Liu, Y., Pang, L., et al. (2021). Discussion on the efficacy mechanism of idiopathic pulmonary fibrosis based on the theory of “lungs generate blood”. Journal of Traditional Chinese Medicine, 32(12), 2987-2989.

[22]Zhang, J., Yuan, W., Xia, L., et al. (2023). Discussion on the relationship between chemotherapy-related bone marrow suppression and the theory of “lungs generate blood”. Journal of Modern Integrated Chinese and Western Medicine, 32(15), 2119-2122+2127.

[23]Borges I, Sena I, Azevedo P, et al. (2017). Lung as a Niche for Hematopoietic Progenitors[J].Stem Cell Reviews and Reports.DOI:10.1007/s12015-017-9747-z.

[24]Wang, Y., & Zhang, W. (2022). Discussion on the role of collaterals in systemic sclerosis combined with interstitial lung disease based on the theory of “lungs as the source of blood”. World Chinese Medicine, 17(15), 2207-2211.

[25]Du, X., & Wang, L. (2024). Experience of Wang Lin in the treatment of pediatric cough variant asthma based on the theory of regulating qi. Jiangxi Journal of Traditional Chinese Medicine, 55(02), 42-44. DOI:10.20141/j.0411-9584.2024.02.13.

[26]Chen, S., Li, X., Zhou, S., et al. (2024). Discussion on the treatment of chest obstruction with Shang Jiongbi Decoction based on the theory of “promoting lung qi descent”. Journal of Integrated Chinese and Western Medicine in Cardio-Cerebrovascular Disease, 22(01), 188-190.

[27]Li, X., & Song, F. (2022). Discussion on the treatment of paroxysmal atrial fibrillation with traditional Chinese medicine rhythm regulation therapy based on the theory of qi and blood spirit differentiation. Chinese Folk Therapy, 30(21), 17-20. DOI:10.19621/j.cnki.11-3555/r.2022.2106.

[28]Wen, Y., & Zhang, H. (2022). Summary of Zhang Hong’s experience in treating lung cancer from the perspective of “stasis”. Journal of Traditional Chinese Medicine and Clinical Research, 34(10), 1834-1837. DOI:10.16448/j.cjtcm.2022.1011.

[29]Jiang, T., Zhu, A., Yang, D., et al. (2021). Interpretation of the pathogenesis of tumor “toxic stasis”. Journal of Zhejiang Chinese Medical University, 45(03), 229-231+239. DOI:10.16466/j.issn1005-5509.2021.03.004.

[30]Zhang, H., Wang, J., & Zhang, Z. (2012). Clinical efficacy and hemorheological index observation of modified Xuefu Zhuyu Tang in the treatment of blood stasis syndrome in middle and late stage non-small cell lung cancer. Chinese Journal of Clinical Research, 4(14), 8-11.

[31]Hou, T., You, F., Yan, R., et al. (2015). Analysis of intervention of “Fire Depression” on tumor microenvironment. Sichuan Traditional Chinese Medicine, 33(5), 23-25.

[32]Cheng, Z., & Shu, Q. (2019). Summary of Professor Shu Qijin’s treatment of lung cancer. Journal of Zhejiang Chinese Medical University, 43(5)